Get the Stockscreener App
16.75
0.06%
-0.01
After Hours:
16.25
-0.50
-2.99%
Overview
News
Price History
Option Chain
Financials
Why CC Down?
Discussions
Forecast
Dividend History
Chemours Company stock is traded at $16.75, with a volume of 1.99M.
It is down -0.06% in the last 24 hours and up +34.86% over the past month.
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
See More
Previous Close:
$16.76
Open:
$16.7
24h Volume:
1.99M
Relative Volume:
0.48
Market Cap:
$2.51B
Revenue:
$5.75B
Net Income/Loss:
$77.00M
P/E Ratio:
34.18
EPS:
0.49
Net Cash Flow:
$-675.00M
1W Performance:
+6.96%
1M Performance:
+34.86%
6M Performance:
+19.99%
1Y Performance:
-2.33%
1-Day Range:
$16.26
$16.86
1-Week Range:
$15.59
$17.03
52-Week Range:
$9.13
$22.38
Chemours Company Stock (CC) Company Profile
Name
Chemours Company
Sector
Industry
Phone
302 773 1000
Address
1007 MARKET STREET, WILMINGTON, DE
Compare CC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CC
Chemours Company
|
16.75 | 2.44B | 5.75B | 77.00M | -675.00M | 0.49 |
|
LIN
Linde plc Ordinary Share
|
482.04 | 221.65B | 33.25B | 6.89B | 5.07B | 14.06 |
|
SHW
Sherwin Williams Co
|
360.10 | 89.12B | 23.08B | 2.54B | 2.15B | 10.08 |
|
ECL
Ecolab Inc
|
272.62 | 76.32B | 15.72B | 2.16B | 1.57B | 7.49 |
|
APD
Air Products Chemicals Inc
|
292.82 | 63.98B | 12.06B | 1.61B | -4.63B | 6.95 |
|
DD
Dupont De Nemours Inc
|
77.29 | 31.86B | 12.61B | 109.00M | 1.32B | -0.47 |
Chemours Company Stock (CC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-25 | Upgrade | Mizuho | Neutral → Outperform |
| Jan-28-25 | Initiated | Truist | Buy |
| Jul-09-24 | Upgrade | UBS | Neutral → Buy |
| Jun-07-24 | Initiated | Mizuho | Neutral |
| Apr-09-24 | Upgrade | BMO Capital Markets | Underperform → Outperform |
| Mar-05-24 | Downgrade | UBS | Buy → Neutral |
| Feb-29-24 | Downgrade | BMO Capital Markets | Outperform → Underperform |
| Dec-01-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-22-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-23 | Upgrade | UBS | Neutral → Buy |
| Jan-11-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-10-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-01-22 | Initiated | Credit Suisse | Underperform |
| Oct-13-22 | Initiated | Goldman | Neutral |
| Oct-05-22 | Downgrade | Argus | Buy → Hold |
| Jun-14-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-10-21 | Initiated | Wolfe Research | Outperform |
| Jun-09-21 | Upgrade | Goldman | Neutral → Buy |
| May-20-21 | Initiated | BofA Securities | Buy |
| May-06-21 | Upgrade | Argus | Hold → Buy |
| Jan-08-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-04-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-30-20 | Initiated | Alembic Global Advisors | Overweight |
| Mar-23-20 | Downgrade | Jefferies | Buy → Hold |
| Feb-14-20 | Upgrade | CFRA | Buy → Strong Buy |
| Nov-06-19 | Upgrade | CFRA | Hold → Buy |
| Aug-20-19 | Upgrade | Susquehanna | Neutral → Positive |
| Aug-09-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-06-19 | Downgrade | Argus | Buy → Hold |
| Aug-05-19 | Downgrade | SunTrust | Buy → Hold |
| Jul-12-19 | Downgrade | Citigroup | Buy → Neutral |
| May-06-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-15-19 | Upgrade | SunTrust | Hold → Buy |
| Feb-19-19 | Downgrade | Susquehanna | Positive → Neutral |
| Jan-08-19 | Initiated | HSBC Securities | Buy |
| Jan-04-19 | Upgrade | Citigroup | Neutral → Buy |
| Nov-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jul-18-18 | Initiated | RBC Capital Mkts | Outperform |
| Jan-30-18 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-06-17 | Downgrade | Goldman | Buy → Neutral |
| Aug-07-17 | Upgrade | UBS | Sell → Neutral |
View All
Chemours Company Stock (CC) Latest News
Corebridge Financial Inc. Sells 163,238 Shares of The Chemours Company $CC - MarketBeat
Millennium Management LLC Has $54.43 Million Position in The Chemours Company $CC - MarketBeat
NCDEQ requires Chemours to expand PFAS well-testing to thousands in Cape Fear - Port City Daily
DEQ requires Chemours to expand PFAS well water testing - Coastal Review
NCDEQ mandates changes to PFAS well testing in the lower Cape Fear area - WHQR
Delivering Trusted Chemistry: A Year of Progress and Purpose - CSRwire
DEQ expands PFAS well testing to more areas in Southeastern NC - WWAYTV3
Can Chemours (CC) Board Refresh Shift Its Long-Term Strategy and Governance Approach? - simplywall.st
Medical Fluoropolymers Market Size, Top share, Demand | Industry Report, 2034 - Straits Research
NCDEQ requiring Chemours to expand well testing in the Lower Cape Fear - WECT
Chemours' Trusted Chemistry in Action: Driving Toward More Sustainable EV Batteries - CSRwire
Price jumps to $134 million to filter PFAS ‘forever chemicals’ from Fayetteville drinking water - CityView NC
Outstanding leadership: Steve Prusak of CPChem and Denise Dignam of Chemours - American Chemistry Council
The Chemours Company $CC Shares Purchased by Advisors Asset Management Inc. - MarketBeat
The Chemours Company (NYSE:CC) Receives $17.38 Average Price Target from Brokerages - MarketBeat
Lobbyists Cash In on Both Sides of PFAS Fight - readsludge.com
Chemours Appoints Mary Cranston as Board Chair, Names Alister Cowan Lead Independent Director - MSN
Chemours Gets Relative Strength Rating Upgrade - MSN
The Chemours Company $CC Shares Sold by Northern Trust Corp - MarketBeat
Chemours, India's SRF partner to boost fluoropolymer supply - Plastics News
SPONSORED How AI and other breakthroughs depend on chemistry - Axios
Can The Chemours Company expand into new marketsTrade Exit Summary & High Conviction Buy Zone Picks - Lancaster City Council
Europe Refrigerant Market Size & Growth Forecast 2025-2032: - openPR.com
EPA intends to rescind PFAS regulations as Chemours seeks to increase production - Port City Daily
Analysts Offer Insights on Materials Companies: Chemours Company (CC) and Ecolab (ECL) - The Globe and Mail
The Chemours Company Breaks Losing Streak — Is the Trend ReversingMarket Risk Summary & Daily Technical Forecast Reports - beatles.ru
Chemours names Mary Cranston as Chair - Indian Chemical News
Is The Chemours Company the Top Chart Pick This WeekTrade Entry Report & Free AI Powered Buy and Sell Recommendations - beatles.ru
A Look at Chemours’s Valuation Following Board Leadership Changes and Strategic Refresh - simplywall.st
Chemical giant dragged to court over shocking scandal in public drinking water: 'Exposed to real and ongoing harm' - The Cool Down
Caption Management LLC Sells 117,980 Shares of The Chemours Company $CC - MarketBeat
Analyzing The Chemours Company with multi timeframe chartsMarket Trend Review & Accurate Trade Setup Notifications - Newser
How to monitor The Chemours Company with trend dashboardsPortfolio Growth Summary & Technical Buy Zone Confirmation - Newser
Highs Report: What are analysts’ price targets for The Chemours CompanyQuarterly Trade Report & Short-Term High Return Strategies - خودرو بانک
Is The Chemours Company stock bottoming outPortfolio Update Report & Growth Oriented Trading Recommendations - Newser
What to do if you’re stuck in The Chemours CompanyWeekly Gains Summary & Smart Money Movement Alerts - Newser
Chart based analysis of The Chemours Company trendsWeekly Trend Summary & Risk Controlled Daily Trade Plans - Newser
Is The Chemours Company stock entering bullish territoryWeekly Stock Summary & Long-Term Growth Stock Strategies - Newser
Chemours names Mary Cranston as Chair of the Board - MSN
VIX Spike: Is now the right time to enter The Chemours CompanyEarnings Recap Report & Real-Time Market Trend Scan - خودرو بانک
Is The Chemours Company in a consolidation phase2025 Key Lessons & Weekly Momentum Picks - خودرو بانک
Chart based exit strategy for The Chemours CompanyQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser
Has The Chemours Company formed a bullish divergenceTrade Signal Summary & Short-Term High Return Strategies - Newser
Khrom Capital Management LLC Sells 755,862 Shares of The Chemours Company $CC - MarketBeat
Pattern recognition hints at The Chemours Company upsideMarket Growth Report & Smart Allocation Stock Tips - Newser
Former Pillsbury CEO Tapped To Lead Chemours Board - Law360
Evaluating The Chemours Company with trendline analysisPortfolio Performance Report & Free Accurate Trade Setup Notifications - Newser
What MACD signals say about The Chemours CompanyQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - Newser
Using RSI to spot recovery in The Chemours CompanyProduct Launch & Advanced Technical Signal Analysis - Newser
Will The Chemours Company benefit from macro trendsGold Moves & Safe Entry Zone Tips - Newser
How to build a custom watchlist for The Chemours CompanyOil Prices & Weekly Watchlist for Consistent Profits - Newser
Chemours Company Stock (CC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):